Cargando…
Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young
OBJECTIVE—1,5-anhydroglucitol (1,5-AG) is a short-term marker of metabolic control in diabetes. Its renal loss is stimulated in hyperglycemic conditions by glycosuria, which results in a lowered plasma concentration. As a low renal threshold for glucose has been described in hepatocyte nuclear facto...
Autores principales: | Skupien, Jan, Gorczynska-Kosiorz, Sylwia, Klupa, Tomasz, Wanic, Krzysztof, Button, Eric A., Sieradzki, Jacek, Malecki, Maciej T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494661/ https://www.ncbi.nlm.nih.gov/pubmed/18492944 http://dx.doi.org/10.2337/dc07-2334 |
Ejemplares similares
-
Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients
por: Stettler, Christoph, et al.
Publicado: (2008) -
Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)
por: Christensen, Alexander S., et al.
Publicado: (2020) -
Terbutaline and the Prevention of Nocturnal Hypoglycemia in Type 1 Diabetes
por: Cooperberg, Benjamin A., et al.
Publicado: (2008) -
1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus
por: Nowak, N., et al.
Publicado: (2013) -
Monogenic Models: What Have the Single Gene Disorders Taught Us?
por: Klupa, Tomasz, et al.
Publicado: (2012)